Paper36979495
LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Zeng Q and 5 others. Biomolecules, 2023. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review. Papers, record 36979495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979495
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Non-alcoholic Fatty Liver Disease | Major topic |
| RNA, Long Noncoding | Major topic |
| Humans | |
| RNA, Circular | |
| Liver | |
| Fibrosis |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31300518 | miRNAs and NAFLD: from pathophysiology to therapy. | Gut | 2019 | https://conductscience.org/library/papers/31300518 | PubMed |
| 2 | 34440652 | Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis. | Cells | 2021 | https://conductscience.org/library/papers/34440652 | PubMed |
| 3 | 27486010 | NAFLD and liver transplantation: Current burden and expected challenges. | J Hepatol | 2016 | https://conductscience.org/library/papers/27486010 | PubMed |
| 4 | 30248223 | Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation. | Obes Rev | 2019 | https://conductscience.org/library/papers/30248223 | PubMed |
| 5 | 34016945 | Targeting circular RNAs as a therapeutic approach: current strategies and challenges. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34016945 | PubMed |
| 6 | 31395983 | The biogenesis, biology and characterization of circular RNAs. | Nat Rev Genet | 2019 | https://conductscience.org/library/papers/31395983 | PubMed |
| 7 | 32595415 | LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells. | Cancer Cell Int | 2020 | https://conductscience.org/library/papers/32595415 | PubMed |
| 8 | 27131369 | A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27131369 | PubMed |
| 9 | 29555473 | Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29555473 | PubMed |
| 10 | 25125077 | Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. | Hepatology | 2015 | https://conductscience.org/library/papers/25125077 | PubMed |
| 11 | 27007508 | Mechanisms of long noncoding RNA function in development and disease. | Cell Mol Life Sci | 2016 | https://conductscience.org/library/papers/27007508 | PubMed |
| 12 | 32258441 | Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis. | Biochem Biophys Rep | 2020 | https://conductscience.org/library/papers/32258441 | PubMed |
| 13 | 27770549 | Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay. | Hepatology | 2017 | https://conductscience.org/library/papers/27770549 | PubMed |
| 14 | 32745314 | LncRNA NEAT1: Shedding light on mechanisms and opportunities in liver diseases. | Liver Int | 2020 | https://conductscience.org/library/papers/32745314 | PubMed |
| 15 | 34416820 | Long Noncoding RNAs and Human Liver Disease. | Annu Rev Pathol | 2022 | https://conductscience.org/library/papers/34416820 | PubMed |
| 16 | 32413192 | Long noncoding RNA CCAT1 inhibits miR-613 to promote nonalcoholic fatty liver disease via increasing LXRα transcription. | J Cell Physiol | 2020 | https://conductscience.org/library/papers/32413192 | PubMed |
| 17 | 34890795 | 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34890795 | PubMed |
| 18 | 34741554 | Global burden of NAFLD and chronic liver disease among adolescents and young adults. | Hepatology | 2022 | https://conductscience.org/library/papers/34741554 | PubMed |
| 19 | 36132427 | Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | https://conductscience.org/library/papers/36132427 | PubMed |
| 20 | 29426937 | Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. | Nat Commun | 2018 | https://conductscience.org/library/papers/29426937 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42746114 | In silico analysis of MALAT1 and H19 lncRNA interactions with the diabetes-related proteins ASK1 and YAP1. | In Silico Pharmacol | 2026 | https://conductscience.org/library/papers/42746114 | PubMed |
| 42706873 | Identifying Co-Expressed lncRNAs Correlated With Traits of Interest in an Animal Model for Metabolic Diseases in Humans. | Anim Genet | 2026 | https://conductscience.org/library/papers/42706873 | PubMed |
| 42704556 | Liquid biopsy: current applications and future directions. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42704556 | PubMed |
| 42576075 | ZNF143 suppresses mitophagy to drive MASLD progression by regulating SMURF1/TRPV1 axis. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42576075 | PubMed |
| 42376277 | CircRNAs in hepatic lipid metabolism: regulatory mechanisms and clinical implications. | Front Genet | 2026 | https://conductscience.org/library/papers/42376277 | PubMed |
| 42308919 | Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis. | Biomed Pharmacother | 2026 | https://conductscience.org/library/papers/42308919 | PubMed |
| 41741417 | Circular RNAs in metabolic health: bridging the gap between molecular biology and therapy. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41741417 | PubMed |
| 41658986 | Clinical biomarkers and biosensors for early detection of metabolic dysfunction-associated steatohepatitis (MASH): a translational perspective. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41658986 | PubMed |
| 41513602 | CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41513602 | PubMed |
| 41399367 | Role of Circular RNAs in Liver Diseases. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/41399367 | PubMed |
| 41226441 | miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226441 | PubMed |
| 41090079 | LncRNA-mRNA integrated networks in the neuroendocrine system of bisphenol a-treated mice induce cellular dysfunctions by disrupting transcriptional homeostasis. | Anim Cells Syst (Seoul) | 2025 | https://conductscience.org/library/papers/41090079 | PubMed |
| 41041848 | Circular RNA hsa_circ_0000118 promotes atrial fibrosis by regulating the microRNA‑34a‑5p/Smad4 axis. | Mol Med Rep | 2025 | https://conductscience.org/library/papers/41041848 | PubMed |
| 41024874 | Extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From intercellular signaling to clinical translation. | World J Hepatol | 2025 | https://conductscience.org/library/papers/41024874 | PubMed |
| 41008718 | Extracellular RNAs in Liquid Biopsy: Applications in MASLD and MASH Diagnosis and Monitoring. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41008718 | PubMed |
| 40794423 | CircDock6 drives metabolic dysfunction-associated steatotic liver disease progression in mice and mouse hepatocytes via mmu-let-7g-5p/insulin-like growth factor 1 receptor regulation. | J Int Med Res | 2025 | https://conductscience.org/library/papers/40794423 | PubMed |
| 40757241 | Staphylococcal nuclease and tudor domain-containing protein 1: An emerging therapeutic target in cancer (Review). | Mol Clin Oncol | 2025 | https://conductscience.org/library/papers/40757241 | PubMed |
| 40556020 | Circ-0000197 derived from porcine milk small extracellular vesicles promotes intestinal barrier function by sponging miR-429. | J Anim Sci Biotechnol | 2025 | https://conductscience.org/library/papers/40556020 | PubMed |
| 40141450 | Identification and Assessment of lncRNAs and mRNAs in PM2.5-Induced Hepatic Steatosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141450 | PubMed |
| 40106182 | Influence of the lncRNA SLC9A3-AS1 on colon cancer and the biological activities of colon cancer cells. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40106182 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979495
GET https://conductscience.org/api/papers/v1/36979495/references?page=2